ArticleBMC chemistry2025
Utility of green chemistry for spectrofluorometric and spectrophotometric analysis of vericiguat via reaction with erythrocin B.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Eco-friendly spectrofluorimetric determination of fenbendazole in pharmaceutical, plasma, and milk samples using erythrosine B as a fluorescent probe.RSC advances · 2026Article
- A Sustainable Spectrofluorimetric Quenching Approach for Determination of Pentoxifylline or Donepezil HCl via Complexation With Erythrosine B: Application to Tablets and Human Plasma.Luminescence : the journal of biological and chemical luminescence · 2026Article
- Enhanced Removal of Erythrosine B Dye Using Chemically Modified Chitosan Beads: A Comparative Evaluation.Molecules (Basel, Switzerland) · 2026Article
- Analysis of capivasertib via ion-pairing with erythrocin B as a spectrofluorometric probe.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Food colorant Erythrosine B (EB) is an antiviral xanthene dye with a wide range of uses as a colorant in cosmetics and medications. Its availability, affordability, quick labeling, and high sensitivity make it an excellent choice for spectrofluorometric and spectrophotometric examination of amine-based medications. Two quick and accurate spectrophotometric and spectrofluorometric methods were developed for the estimation of vericiguat in this case. To create an ion-pair complex at pH 4 using the Britton Robinson buffer, the suggested methods relied on the interaction between the amino groups of the medication under study and the phenolic group of EB. The quenching effect of the vericigaute drug of EB at excitation/emission wavelengths of 530.0/550.0 nm. This method demonstrated a limit of detection (LOD) of 0.036 µg/mL and a limit of quantification (LOQ) of 0.110 µg/mL, showing rectilinear response in the concentration range of 0.05-0.5 µg/mL. Additionally, the absorbance of the produced ion-pair complex was evaluated using the colorimetric approach at 560 nm, displaying a linearity range of 0.5-10.0 µg/mL with LOD = 0.428 µg/mL and LOQ = 1.298 µg/mL. The greenness of the developed approaches was determined by GAPT and AGREE software for evaluating the suggested methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.